Cargando…
Off-Label Uses of Rituximab in Dermatology
PURPOSE OF REVIEW: Rituximab has transformed the treatment of B-cell malignancies and rheumatoid arthritis in the past 2 decades. More recently, this anti-CD20 monoclonal antibody has seen increasing usage in the field of dermatology. This review highlights the evidence supporting its use in several...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534735/ https://www.ncbi.nlm.nih.gov/pubmed/36217351 http://dx.doi.org/10.1007/s13671-022-00375-4 |